Also trades as: MMEDV (NASDAQ) · $vol 1M
MMED NASDAQ
MiniMed Group, Inc.
1W: +4.9%
1M: -6.6%
3M: +5.8%
YTD: +0.9%
$18.93
+0.27 (+1.45%)
After Hours: $18.96 (+0.04, +0.18%)
Weekly Expected Move ±7.7%
$16
$17
$18
$20
$21
Credit Risk of going bust: not rated Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.2B
52W Range10.65-24.43
Volume5,287,805
Avg Volume5,127,760
Beta-3.71
Dividend—
Analyst Ratings
Company Info
CEOQue Thanh Dallara
Employees8,000
SectorHealthcare
IndustryMedical - Equipment & Services
IPO Date2026-03-05
Websiteminimed.com
18000 Devonshire Street
Northridge, CA 91325
US
Northridge, CA 91325
US
(763) 514-4000
About MiniMed Group, Inc.
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Latest News
How Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King?
Medtronic reports final results of MiniMed share swap, exits stake
Medtronic's MiniMed exchange offer oversubscribed; 18.3% acceptance
Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There?
Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Lofton Kevin E | A-Award | 836 | — | 2026-10-15 |
| Dianaty Ali | A-Award | 11,108 | — | 2026-10-15 |
| Chandrasena Gillian | A-Award | 1,800 | — | 2026-10-15 |
| Medtronic plc | J-Other | 252,813,348 | — | 2026-10-15 |
| Bricker Amy | 0 | — | 2026-10-15 |